JP2012072106A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012072106A5 JP2012072106A5 JP2010245227A JP2010245227A JP2012072106A5 JP 2012072106 A5 JP2012072106 A5 JP 2012072106A5 JP 2010245227 A JP2010245227 A JP 2010245227A JP 2010245227 A JP2010245227 A JP 2010245227A JP 2012072106 A5 JP2012072106 A5 JP 2012072106A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- caffeine
- loxoprofen
- methylephedrine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 7
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims 6
- 229960002373 loxoprofen Drugs 0.000 claims 5
- 229960001948 caffeine Drugs 0.000 claims 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims 4
- BAZQYVYVKYOAGO-UHFFFAOYSA-M loxoprofen sodium hydrate Chemical compound O.O.[Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 BAZQYVYVKYOAGO-UHFFFAOYSA-M 0.000 claims 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 3
- 229960002179 ephedrine Drugs 0.000 claims 3
- NTCYWJCEOILKNG-ROLPUNSJSA-N [(1r,2s)-1-hydroxy-1-phenylpropan-2-yl]-dimethylazanium;chloride Chemical compound Cl.CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 NTCYWJCEOILKNG-ROLPUNSJSA-N 0.000 claims 2
- 229940073563 dl- methylephedrine hydrochloride Drugs 0.000 claims 2
- -1 loxoprofen sodium anhydride Chemical class 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- CAVQBDOACNULDN-NRCOEFLKSA-N (1s,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-NRCOEFLKSA-N 0.000 claims 1
- RCQXSQPPHJPGOF-UHFFFAOYSA-N caffeine citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C RCQXSQPPHJPGOF-UHFFFAOYSA-N 0.000 claims 1
- 229960002031 caffeine citrate Drugs 0.000 claims 1
- LCHGOKZNRDAXEK-UHFFFAOYSA-N caffeine monohydrate Chemical compound O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C LCHGOKZNRDAXEK-UHFFFAOYSA-N 0.000 claims 1
- 239000002274 desiccant Substances 0.000 claims 1
- 229940005636 dl- methylephedrine Drugs 0.000 claims 1
- 229960002221 methylephedrine Drugs 0.000 claims 1
- 229940051020 methylephedrine hydrochloride Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 claims 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 claims 1
- 229960004159 pseudoephedrine sulfate Drugs 0.000 claims 1
- JWBPVFVNISJVEM-UHFFFAOYSA-M sodium caffeine benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2C JWBPVFVNISJVEM-UHFFFAOYSA-M 0.000 claims 1
- 239000007909 solid dosage form Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010245227A JP5798734B2 (ja) | 2009-10-30 | 2010-11-01 | ロキソプロフェン含有医薬の組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009250953 | 2009-10-30 | ||
| JP2009250953 | 2009-10-30 | ||
| JP2010193774 | 2010-08-31 | ||
| JP2010193774 | 2010-08-31 | ||
| JP2010245227A JP5798734B2 (ja) | 2009-10-30 | 2010-11-01 | ロキソプロフェン含有医薬の組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012072106A JP2012072106A (ja) | 2012-04-12 |
| JP2012072106A5 true JP2012072106A5 (enExample) | 2013-12-19 |
| JP5798734B2 JP5798734B2 (ja) | 2015-10-21 |
Family
ID=46168714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010245227A Active JP5798734B2 (ja) | 2009-10-30 | 2010-11-01 | ロキソプロフェン含有医薬の組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5798734B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6197231B2 (ja) * | 2012-12-13 | 2017-09-20 | シオノギヘルスケア株式会社 | ロキソプロフェン含有医薬組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3481052B2 (ja) * | 1996-06-05 | 2003-12-22 | 三洋電機株式会社 | 固形製剤供給装置及び固形製剤供給装置に用いられる乾燥剤 |
| JP2986433B2 (ja) * | 1997-08-21 | 1999-12-06 | 株式会社ピーエムシーコーポレーション | 錠剤瓶の緩衝マット |
| JP4936579B2 (ja) * | 1997-09-05 | 2012-05-23 | 第一三共株式会社 | ロキソプロフェン含有医薬製剤 |
| JPH11206849A (ja) * | 1998-01-29 | 1999-08-03 | Dai Ichi Seiyaku Co Ltd | 薬剤用乾燥体及び薬剤包装体 |
| JP4357016B2 (ja) * | 1998-11-06 | 2009-11-04 | 第一三共株式会社 | ロキソプロフェンを含有する医薬組成物 |
| JP2000290199A (ja) * | 1999-03-31 | 2000-10-17 | Taisho Pharmaceut Co Ltd | 経口用医薬組成物 |
| JP2001233765A (ja) * | 2000-02-24 | 2001-08-28 | Ss Pharmaceut Co Ltd | 感冒薬 |
| JP2002316927A (ja) * | 2001-04-19 | 2002-10-31 | Taisho Pharmaceut Co Ltd | 感冒用組成物 |
| JP2003261442A (ja) * | 2002-03-11 | 2003-09-16 | Toyo Capsule Kk | 塩酸プソイドエフェドリンを含む軟カプセル剤 |
| JP2007314517A (ja) * | 2006-04-27 | 2007-12-06 | Daiichi Sankyo Healthcare Co Ltd | ロキソプロフェンを含有する鎮咳又は去痰のための医薬組成物 |
| WO2008086852A1 (de) * | 2007-01-20 | 2008-07-24 | Merck Patent Gmbh | Packung enthaltend weichkapseln |
| JP5006900B2 (ja) * | 2009-04-16 | 2012-08-22 | 第一三共株式会社 | ｄｌ−塩酸メチルエフェドリンを含有する医薬組成物 |
-
2010
- 2010-11-01 JP JP2010245227A patent/JP5798734B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
| JP2012255026A5 (enExample) | ||
| JP2015515475A5 (enExample) | ||
| JP2009537554A5 (enExample) | ||
| EA201071204A1 (ru) | Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности | |
| JP2013542247A5 (enExample) | ||
| JP2012031131A5 (enExample) | ||
| JP2011201907A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| JP2014218522A5 (enExample) | ||
| HRP20150770T1 (hr) | Terapijska kombinacija koja sadrži dolutegravir, abakavir i lamivudin | |
| JP2011522896A5 (enExample) | ||
| PH12013500172A1 (en) | Use of binders for manufacturing storage stable formulations | |
| JP2012031147A5 (enExample) | ||
| UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
| JP2011527299A5 (enExample) | ||
| JP2013507408A5 (enExample) | ||
| EA201300053A1 (ru) | Фосфатсвязывающий препарат для удобного приема | |
| EP3228311A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
| JP2015537009A5 (enExample) | ||
| UA101407C2 (ru) | Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат | |
| TR201001417A1 (tr) | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu | |
| JP2018039810A5 (enExample) | ||
| JP2011068692A5 (enExample) | ||
| WO2014006636A3 (en) | Stable compositions of fesoterodine |